Radiopharm Theranostics (RAD) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock RAD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Radiopharm Theranostics Sees Revenue Surge Despite Continued LossesAugust 29, 2025 | tipranks.comRadiopharm Theranostics Ltd. ADR (RADX) Stock Price Today - WSJAugust 21, 2025 | wsj.comRadiopharm Theranostics Hosts Webinar Series on Radiopharmaceutical TherapiesAugust 21, 2025 | msn.comRadiopharm Theranostics trading resumesAugust 20, 2025 | msn.comRadiopharm Theranostics trading halted, volatility trading pauseAugust 20, 2025 | msn.comDr Boreham’s Crucible: In the shadow of giants, but can this biotech become a tumour-tackling titan?August 18, 2025 | msn.comRADX: July 2025 UpdateAugust 4, 2025 | finance.yahoo.comRadiopharm Theranostics: Promising Pipeline and Strategic Advancements Drive Buy RatingJuly 30, 2025 | tipranks.comRadiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)July 28, 2025 | finance.yahoo.comRadiopharm Theranostics Gains FDA Approval for Phase I Study of Innovative Cancer TreatmentJuly 27, 2025 | tipranks.comRadiopharm Theranostics Secures A$4.5 Million R&D Tax IncentiveJuly 15, 2025 | tipranks.comRadiopharm Theranostics Limited (RADX) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comRadiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in AustraliaJune 24, 2025 | finance.yahoo.comRadiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain MetastasesJune 11, 2025 | finance.yahoo.comRadiopharm Theranostics Expands Market Presence with New ASX QuotationJune 11, 2025 | tipranks.comRadiopharm Theranostics Issues New Shares, Ensures ComplianceJune 11, 2025 | tipranks.comRadiopharm Theranostics’ RAD 101 Receives FDA Fast Track DesignationJune 10, 2025 | tipranks.comRadiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid TumorsJune 4, 2025 | finance.yahoo.comradiopharm theranostics shares preclinical data on new cancer therapyJune 3, 2025 | uk.investing.comRadiopharm Theranostics Initiates Phase 1 Trial for Novel Cancer TreatmentJune 3, 2025 | tipranks.comRadiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour UptakeJune 2, 2025 | finance.yahoo.comRadiopharm Theranostics Advances RV01 Program with Promising Preclinical DataJune 1, 2025 | tipranks.comIndependent Non-Executive Director of Radiopharm Theranostics Picks Up 48% More StockJune 1, 2025 | finance.yahoo.comRadiopharm Theranostics Director Increases ShareholdingMay 30, 2025 | tipranks.comITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177May 19, 2025 | finance.yahoo.comRadiopharm Theranostics Secures Lutetium-177 Supply Agreement with ITMMay 19, 2025 | tipranks.comIs Radiopharm Theranostics (RADX) the Best Australian Stock to Buy According to Analysts?May 16, 2025 | msn.comRADX: Initiating Coverage – Adding a Radioisotope to Precision OncologyMay 12, 2025 | msn.comRadiopharm Theranostics Advances Phase 1 Trial for 177Lu-RAD204May 11, 2025 | tipranks.comRadiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global ConferenceMay 7, 2025 | finance.yahoo.comMaxim Group Initiates Coverage of Radiopharm Theranostics Limited - Depositary Receipt () (RADX) with Buy RecommendationMay 2, 2025 | msn.comRadiopharm advances brain cancer diagnosis with new trialApril 29, 2025 | investing.comRadiopharm Theranostics Advances in Clinical Trials and Secures Major InvestmentApril 28, 2025 | tipranks.comRadiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisApril 28, 2025 | finance.yahoo.comRadiopharm Theranostics Initiates U.S. Phase 2b Imaging Study for Brain MetastasisApril 27, 2025 | tipranks.comRadiopharm Theranostics Ltd ADR (RADX)April 17, 2025 | investing.comRadiopharm Theranostics: Radiotherapeutic Biotech With PD-L1 And HER2 TargetingMarch 28, 2025 | seekingalpha.comRadiopharm Theranostics Ltd. ADRMarch 18, 2025 | wsj.comNew RAD202 Data Confirms Positive Tumor Uptake and Favorable BiodistributionMarch 18, 2025 | markets.businessinsider.comRadiopharm Theranostics: New RAD202 Data Confirms Positive Tumor Uptake and Favorable BiodistributionMarch 17, 2025 | finanznachrichten.deRadiopharm Theranostic announces presentation of RAD202 dataMarch 17, 2025 | markets.businessinsider.comRadiopharm Theranostics Reports Positive Data on RAD202 for HER2-Positive TumorsMarch 16, 2025 | tipranks.comRadiopharm Theranostics Engages in Key Healthcare ConferencesMarch 13, 2025 | tipranks.comB. Riley Securities Initiates Coverage of Radiopharm Theranostics Limited - Depositary Receipt () (RADX) with Buy RecommendationMarch 12, 2025 | msn.comRadiopharm Theranostic initiated with a Buy at B. RileyMarch 12, 2025 | markets.businessinsider.comRADX Stock trading resumesMarch 5, 2025 | markets.businessinsider.comPositive Signs As Multiple Insiders Buy Radiopharm Theranostics StockFebruary 27, 2025 | finance.yahoo.comRadiopharm Theranostics to Present at B. Riley Precision Oncology ConferenceFebruary 17, 2025 | tipranks.comNew Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain MetastasesFebruary 11, 2025 | markets.businessinsider.comRadiopharm announces publication of clinical trial data highlighting RAD 101February 10, 2025 | markets.businessinsider.com Get Radiopharm Theranostics News Delivered to You Automatically Sign up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RAD Media Mentions By Week RAD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RAD News Sentiment▼0.000.92▲Average Medical News Sentiment RAD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RAD Articles This Week▼01▲RAD Articles Average Week Get the Latest News and Ratings for RAD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Radiopharm Theranostics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Avacta Group News Today Theratechnologies News Today Cybin News Today NervGen Pharma News Today 4basebio News Today Bioventix News Today Scancell News Today Helix BioPharma News Today Medicenna Therapeutics News Today Ondine Biomedical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:RAD) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Radiopharm Theranostics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Radiopharm Theranostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RAD Stock Alerts